Gelesis Holdings Inc.

PINK:GLSHQ USA Biotechnology
Market Cap
$0.96
Market Cap Rank
#45857 Global
#14359 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
--
All Time High
$0.01
About

Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Furt… Read more

Gelesis Holdings Inc. (GLSHQ) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2023: -0.033x

Based on the latest financial reports, Gelesis Holdings Inc. (GLSHQ) has a cash flow conversion efficiency ratio of -0.033x as of June 2023.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($617.00K) by net assets ($-18.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Gelesis Holdings Inc. - Cash Flow Conversion Efficiency Trend (2020–2022)

This chart illustrates how Gelesis Holdings Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Gelesis Holdings Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gelesis Holdings Inc. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Gelesis Holdings Inc. (2020–2022)

The table below shows the annual cash flow conversion efficiency of Gelesis Holdings Inc. from 2020 to 2022.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 $-12.47 Million $-77.73 Million 6.235x --
2021-12-31 $0.00 $-55.29 Million x --
2020-12-31 $235.37 Million $-861.35K -0.004x --